Skip to content

The Archive · A Source

GEMMABio Announces First Patient Dosed in CHARISMA Trial

PR Newswire 2025 www.prnewswire.com/news-releases/gemmabio-announces-first-patient-dosed-in-charisma-trial-of-gb221-investigational-nextgeneration-gene-therapy-for-spinal-muscular-atrophy-type-1-sma1-302698146.html